Design, synthesis and biological evaluation of novel DPP-IV inhibitors

被引:0
作者
Karelia, Chirag [1 ]
Parmar, Kailash [1 ]
Teli, Divya [1 ]
Chhabria, Mahesh [1 ]
机构
[1] LM Coll Pharm, Dept Pharmaceut Chem, Ahmadabad 380009, Gujarat, India
关键词
Type; 2; diabetes; DPP-IV inhibitor; 3D QSAR pharmacophore; virtual screening; S; N-acetal; N; DERIVATIVES;
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Diabetes mellitus is one of the top ten leading causes of death worldwide. DPP-IV inhibition became an attractive target in controlling type 2 diabetes. Because of the several adverse effects associated with current DPP-IV inhibitors, the discovery and development of newer DPP-IV inhibitors are crucial. Ligand-based 3D QSAR pharmacophore modeling method was used in recognizing the important molecular chemical features of potent DPP-IV inhibitors. The best pharmacophore model (Hypo 1) was generated using HypoGen algorithm of Discovery Studio 2.1 (DS). Based on the Hypo 1 model, four novel designed compounds were synthesized, characterized and screened for their DPP-IV inhibitory potentials. All the compounds (9), (10), (11) and (12) showed IC50 values ranging from 0.035-0.35 mu M.
引用
收藏
页码:1227 / 1235
页数:9
相关论文
共 19 条
[1]  
Bhadti V. S., 1985, THESIS GUJARAT U, P106
[2]   The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes [J].
Deng, Jifeng ;
Peng, Li ;
Zhang, Guicheng ;
Lan, Xiaobing ;
Li, Chufang ;
Chen, Fuxin ;
Zhou, Yayao ;
Lin, Zuoxian ;
Chen, Ling ;
Dai, Renke ;
Xu, Hongjiang ;
Yang, Ling ;
Zhang, Xiquan ;
Hu, Wenhui .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2011, 46 (01) :71-76
[3]   The efficacy and safety of combinations of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of type 2 diabetes or obese adults: a systematic review and meta-analysis [J].
Guo, Man ;
Gu, Junling ;
Teng, Fangyuan ;
Chen, Jiao ;
Ma, Xiumei ;
Chen, Qing ;
Pu, Yueli ;
Jiang, Zongzhe ;
Long, Yang ;
Xu, Yong .
ENDOCRINE, 2020, 67 (02) :294-304
[4]   Searching for bioactive conformations of drug-like ligands with current force fields: how good are we? [J].
Gursoy, Oya ;
Smiesko, Martin .
JOURNAL OF CHEMINFORMATICS, 2017, 9
[5]   Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors [J].
John, Shalini ;
Thangapandian, Sundarapandian ;
Arooj, Mahreen ;
Hong, Jong Chan ;
Kim, Kwang Dong ;
Lee, Keun Woo .
BMC BIOINFORMATICS, 2011, 12 :S4
[6]   ALPHA-OXOKETENE-S,S-ACETAL, N,S-ACETAL AND N,N-ACETAL - VERSATILE INTERMEDIATES IN ORGANIC-SYNTHESIS [J].
JUNJAPPA, H ;
ILA, H ;
ASOKAN, CV .
TETRAHEDRON, 1990, 46 (16) :5423-5506
[7]   Non-peptide angiotensin II receptor antagonists: Chemical feature based pharmacophore identification [J].
Krovat, EM ;
Langer, T .
JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (05) :716-726
[8]   Design, synthesis and biological evaluation of novel pyrimidinedione derivatives as DPP-4 inhibitors [J].
Li, Ning ;
Wang, Li-Jun ;
Jiang, Bo ;
Guo, Shu-Ju ;
Li, Xiang-Qian ;
Chen, Xue-Chun ;
Luo, Jiao ;
Li, Chao ;
Wang, Yi ;
Shi, Da-Yong .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (12) :2131-2135
[9]   Synthesis and antiviral activities of cyanoacrylate derivatives containing an α-aminophosphonate moiety [J].
Long, Ning ;
Cai, Xue-Jian ;
Song, Bao-An ;
Yang, Song ;
Chen, Zhuo ;
Bhadury, Pinaki S. ;
Hu, De-Yu ;
Jin, Lin-Hong ;
Xue, Wei .
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2008, 56 (13) :5242-5246
[10]   Chemical methods for the synthesis and modification of neoclerodane diterpenes [J].
Lozama, Anthony ;
Prisinzano, Thomas E. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (18) :5490-5495